Purdue Gets Six-Month Shield From Opioid Litigation

Drug Industry Daily
A A
Purdue Pharma has been granted a six-month shield from opioid litigation to allow the company to continue settlement negotiations.

To View This Article:

Login

Subscribe To Drug Industry Daily